The expiry of the patent on sildenafil in June 2013 allowed the NHS to purchase generic sildenafil from other pharmaceutical companies for a competitive price, subsequently reducing the price per item from £31.31 in 2012 to £2.53 in 2014.11 This also allowed sildenafil to be removed from the Selected List Scheme, which restricted prescriptions of certain drugs in May 2014, allowing more men access to the medicine on the NHS, which potentially increased the number of items prescribed.21 The patent on tadalafil also expired in November 2017, leading to a 49% decrease in cost per item from £49.40 in 2017 to £25.12 in 2018. The data suggest that more men are seeking help or being assessed for ED in primary care. The increased presentations and, hence, prescribing for EDs allows further opportunities to screen for the associated risk factors for ED.
FAQ Section
The expiry of the patent on sildenafil in June 2013 allowed the NHS to purchase generic sildenafil from other pharmaceutical companies for a competitive price, subsequently reducing the price per item from £31.31 in 2012 to £2.53 in 2014.11 This also allowed sildenafil to be removed from the Selected List Scheme, which restricted prescriptions of certain drugs in May 2014, allowing more men access to the medicine on the NHS, which potentially increased the number of items prescribed.21 The patent on tadalafil also expired in November 2017, leading to a 49% decrease in cost per item from £49.40 in 2017 to £25.12 in 2018. The data suggest that more men are seeking help or being assessed for ED in primary care. The increased presentations and, hence, prescribing for EDs allows further opportunities to screen for the associated risk factors for ED. These include: CVDs such as hypertension, coronary artery disease, peripheral vasculopathy; endocrine disorders such as diabetes, metabolic syndrome, and hyperthyroidisim; as well as assessment of psychogenic risk factors and medication-induced ED.2 Prescribers should be aware of the wider organic, psychogenic nature and linked risk factors of ED including diabetes, vascular disorders, and mental health conditions. The cause of ED needs to be established before treatment can commence and patients should be referred to specialist clinics where appropriate.
Levitra Brand
Guidelines recommend that a physical examination, including genitourinary, endocrine, vascular, and neurological systems, is undertaken. This can reveal any unsuspected diagnoses, such as Peyronie’s disease, pre-malignant or malignant genital lesions, prostatic enlargement or irregularity or nodularity, or signs and symptoms suggesting hypogonadism.2,3 It is, however, unclear how often patients are screened for the red-flag symptoms. Long-term safety outcomes of PDE-5Is are not understood. Prescribers should, therefore, reassess the continuous use of these drugs on a periodic basis.22,23 Reclassification to allow ‘pharmacy-only’ supply of drugs to free-up GP time and resources have faced successes and barriers in the past.24–26 For example, reclassification of drugs such as chloramphenicol eye products, mild steroids, and antifungal products have been positively received by patients, GPs, and pharmacists. However, reclassified pharmacy version of simvastatin was not adopted in practice to the same extent.24 Research on community pharmacist and patient perspectives on the need, supply, and aspects of risk assessments and referrals are warranted. These include: CVDs such as hypertension, coronary artery disease, peripheral vasculopathy; endocrine disorders such as diabetes, metabolic syndrome, and hyperthyroidisim; as well as assessment of psychogenic risk factors and medication-induced ED.2 Prescribers should be aware of the wider organic, psychogenic nature and linked risk factors of ED including diabetes, vascular disorders, and mental health conditions.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 100mg | 270 + 10 Pills | 270.47€ 257.59€ | |
| Viagra Generic | 25mg | 360 + 10 Pills | 213.68€ 203.50€ | |
| Viagra Generic | 100mg | 90 + 6 Pills | 129.02€ 122.88€ | |
| Viagra Generic | 200mg | 30 + 2 Pills | 83.07€ 79.11€ | |
| Kamagra Polo | 100mg | 12 Pills | 60.21€ 57.34€ | |
| Viagra Generic | 150mg | 120 + 8 Pills | 177.58€ 169.12€ | |
| Viagra Generic | 150mg | 60 + 4 Pills | 111.25€ 105.95€ | |
| Kamagra Polo | 100mg | 120 + 6 Pills | 327.15€ 311.57€ | |
| Kamagra Oral Jelly | 100mg | 63 + 7 Sachets | 224.18€ 213.50€ | |
| Kamagra Soft Tabs | 100mg | 32 Pills | 120.11€ 114.39€ | |
| Kamagra | 100mg | 84 + 6 Pills | 264.44€ 251.85€ |
The cause of ED needs to be established before treatment can commence and patients should be referred to specialist clinics where appropriate. Guidelines recommend that a physical examination, including genitourinary, endocrine, vascular, and neurological systems, is undertaken. This can reveal any unsuspected diagnoses, such as Peyronie’s disease, pre-malignant or malignant genital lesions, prostatic enlargement or irregularity or nodularity, or signs and symptoms suggesting hypogonadism.2,3 It is, however, unclear how often patients are screened for the red-flag symptoms. Long-term safety outcomes of PDE-5Is are not understood. Prescribers should, therefore, reassess the continuous use of these drugs on a periodic basis.22,23 Reclassification to allow ‘pharmacy-only’ supply of drugs to free-up GP time and resources have faced successes and barriers in the past.24–26 For example, reclassification of drugs such as chloramphenicol eye products, mild steroids, and antifungal products have been positively received by patients, GPs, and pharmacists.
Society and culture
Expiry of patents leading to launch of generics: The patent expiry of branded sildenafil drugs such as Viagra has led to the launch of generic versions by many pharmaceutical companies. The low cost of generics compared to branded equivalents is boosting their adoption. Companies are focused on developing generic sildenafil formulations to capture the market share. The availability of generics has made ED treatment more accessible and affordable, thereby driving the growth of the sildenafil drug market. Favorable reimbursement policies and government support: The reimbursement coverage for ED drugs by public and private healthcare insurance providers is improving in many countries.
Viagra Generic
This is encouraging patients to opt for sildenafil treatment. Initiatives by governments and NGOs to spread awareness about ED and available treatment options led to the greater adoption of sildenafil drugs. Government support to expand healthcare infrastructure is also fueling the growth of the sildenafil drug market. Emerging use in other therapeutic applications: While ED remains the primary application sildenafil has shown promise in other indications like pulmonary hypertension and altitude sickness. The widening scope of sildenafil in other untapped applications and ongoing research for further therapeutic uses represents significant growth opportunities for the market in the long run. However, reclassified pharmacy version of simvastatin was not adopted in practice to the same extent.24 Research on community pharmacist and patient perspectives on the need, supply, and aspects of risk assessments and referrals are warranted. GPs and patient experiences of access to sildenafil from pharmacy also need to be further explored.
| Pharmacy Name | Location | Price per Tablet (€) | Available Pack Sizes |
|---|---|---|---|
| Dublin Meds | Dublin | 14-16 | 10, 20, 30 |
| Cork Pharmacy | Cork | 12-15 | 10, 20 |
| Galway Health | Galway | 13 | 20 |
| Limerick Drugs | Limerick | 11-14 | 10, 30 |
Results of this study suggest that more men are being screened for, or seeking help with, ED.
Understanding Brand Viagra and Its Availability
GPs and patient experiences of access to sildenafil from pharmacy also need to be further explored. Results of this study suggest that more men are being screened for, or seeking help with, ED. The two-fold observed increase in the population adjusted rate of prescriptions over the past 10 years is less likely to be accounted for by other factors. Promotion of sildenafil by pharmaceutical industries since being made available over the counter for pharmacy sales could have raised awareness of ED among the general public. Higher rate of prescribing in deprived regions offers opportunity for monitoring of linked health conditions such as CVD and diabetes.
Cialis Soft Tabs
Reclassification of sildenafil to pharmacy medicine had a modest impact on prescribing practices. This study was funded by the University of Birmingham. This study represents secondary analysis of the information retrieved from publicly available anonymised datasets and does not warrant formal ethical approval. The authors declare that no competing interests exist. This article is Open Access: CC BY license ( Sildenafil Drug Market is estimated to be valued at USD 3.53 Bn in 2026 and is expected to reach USD 5.63 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033. The two-fold observed increase in the population adjusted rate of prescriptions over the past 10 years is less likely to be accounted for by other factors. Promotion of sildenafil by pharmaceutical industries since being made available over the counter for pharmacy sales could have raised awareness of ED among the general public. Higher rate of prescribing in deprived regions offers opportunity for monitoring of linked health conditions such as CVD and diabetes. Reclassification of sildenafil to pharmacy medicine had a modest impact on prescribing practices.
Why Do Viagra Rules Differ Across Europe?
Expanding clinical evidence and physician prescriptions will support the increasing utilization of sildenafil drugs. Development of novel drug delivery systems: Pharmaceutical companies are engaged in developing innovative drug delivery systems such as oral disintegrating tablets, nasal sprays, topical gels, and others to improve efficacy, safety, convenience, and compliance of sildenafil treatment. The advent of advanced drug delivery platforms provides an opportunity to differentiate brand offerings and gain competitive advantage in the market. This study was funded by the University of Birmingham. This study represents secondary analysis of the information retrieved from publicly available anonymised datasets and does not warrant formal ethical approval. The authors declare that no competing interests exist.
- In Ireland, sildenafil costs can vary seasonally due to demand.
- Generics of sildenafil are typically 30-50% cheaper than branded versions.
- Bulk purchasing may provide savings on sildenafil in Ireland.
- Irish online pharmacies often provide discreet packaging at competitive prices.
- Prescription requirements impact the final price of sildenafil in Ireland.
This article is Open Access: CC BY license ( Sildenafil Drug Market is estimated to be valued at USD 3.53 Bn in 2026 and is expected to reach USD 5.63 Bn in 2033, exhibiting a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that is used to treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It helps improve blood flow to the penis to achieve and maintain an erection, thus making it an effective treatment for impotence. The key drivers of the sildenafil drug market include the rising prevalence of ED, growing geriatric population, increasing awareness about ED treatment options, and high risk factors like obesity, diabetes, and smoking. The sildenafil drug market is segmented into drug type, indication, distribution channel, dosage form, and region. By drug type, the market is segmented into branded drugs, generics, and over-the-counter (OTC) drugs.
Route of administration
The growth of the market in Europe is due to growing geriatric population, increasing prevalence of chronic diseases, and launches of new generic ED drugs. The Asia Pacific market is expected to be the fastest-growing market for sildenafil drug market, with a CAGR of over 9% during the forecast period. The growth of the market in Asia Pacific is due to expanding patient population, rising healthcare expenditure, and growth in online sales of ED drugs. Sildenafil Drug Market Share (%), By Region, 2026 To learn more about this report, Request Free Sample The sildenafil drug market has shown strong growth over the past few years driven by increasing prevalence of erectile dysfunction among men across various age groups. Rising awareness about treatment options and availability of generic versions have also propelled market expansion.
Erectile dysfunction
However, social stigma continues to restrict many patients from sildenafil 50mg tablet openly seeking medical help, proving a growth barrier. Additionally, availability of alternative treatment modes like penile implants and counseling pose competition. North America currently reigns as the dominant region in the sildenafil market owing to growing adoption rates and reduced price points following introduction of generics. Presence of major pharmaceutical manufacturers as well as high medical awareness among patients have further strengthened its position. Meanwhile, Asia Pacific is expected to emerge as the most lucrative territory over the coming years. The generics segment accounts for the largest market share due to patent expiration of branded drugs and increasing demand for low-cost generics globally.
- The cost of sildenafil in Ireland has decreased over the past years due to generics.
- Price comparison tools help find the best sildenafil deals in Ireland.
- Some Irish pharmacies offer loyalty programs for regular sildenafil buyers.
- Price fluctuations occur depending on market demand and supply.
- Consulting a healthcare provider helps determine the most cost-effective option.
Generics are expected to witness significant growth over the forecast period.
To buy male enhancement pills online is a matter of trust
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that is used to treat erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). It helps improve blood flow to the penis to achieve and maintain an erection, thus making it an effective treatment for impotence. The key drivers of the sildenafil drug market include the rising prevalence of ED, growing geriatric population, increasing awareness about ED treatment options, and high risk factors like obesity, diabetes, and smoking. The sildenafil drug market is segmented into drug type, indication, distribution channel, dosage form, and region. By drug type, the market is segmented into branded drugs, generics, and over-the-counter (OTC) drugs.
Competing interests
The generics segment accounts for the largest market share due to patent expiration of branded drugs and increasing demand for low-cost generics globally. Generics are expected to witness significant growth over the forecast period. North America is expected to be the largest market for sildenafil drug market during the forecast period, accounting for over 45.8% of the market share in 2026. The growth of the market in North America is due to high awareness about ED, easy availability, and access to ED drugs, and presence of major players in the region. The Europe market is expected to be the second-largest market for sildenafil drug market, accounting for over 25% of the market share in 2026. North America is expected to be the largest market for sildenafil drug market during the forecast period, accounting for over 45.8% of the market share in 2026. The growth of the market in North America is due to high awareness about ED, easy availability, and access to ED drugs, and presence of major players in the region. The Europe market is expected to be the second-largest market for sildenafil drug market, accounting for over 25% of the market share in 2026. The growth of the market in Europe is due to growing geriatric population, increasing prevalence of chronic diseases, and launches of new generic ED drugs.
| Dosage (mg) | Average Price per Tablet (€) | Common Brands |
|---|---|---|
| 25 | 8 | Generic, Kamagra |
| 50 | 12 | Pfizer, Bluepill |
| 100 | 15 | Viagra, Revatio |
The Asia Pacific market is expected to be the fastest-growing market for sildenafil drug market, with a CAGR of over 9% during the forecast period. The growth of the market in Asia Pacific is due to expanding patient population, rising healthcare expenditure, and growth in online sales of ED drugs. Sildenafil Drug Market Share (%), By Region, 2026 To learn more about this report, Request Free Sample The sildenafil drug market has shown strong growth over the past few years driven by increasing prevalence of erectile dysfunction among men across various age groups. Rising awareness about treatment options and availability of generic versions have also propelled market expansion. However, social stigma continues to restrict many patients from sildenafil 50mg tablet openly seeking medical help, proving a growth barrier. Additionally, availability of alternative treatment modes like penile implants and counseling pose competition. North America currently reigns as the dominant region in the sildenafil market owing to growing adoption rates and reduced price points following introduction of generics. Presence of major pharmaceutical manufacturers as well as high medical awareness among patients have further strengthened its position. Meanwhile, Asia Pacific is expected to emerge as the most lucrative territory over the coming years. This can be attributed to improving access to healthcare in countries like China and India coupled with rising standards of living. While lifestyle diseases continue pushing diagnostic volumes, favorable regulations supporting generic accessibility can further drive volume growth.
Why Is Fake Viagra a Serious Risk?
This can be attributed to improving access to healthcare in countries like China and India coupled with rising standards of living. While lifestyle diseases continue pushing diagnostic volumes, favorable regulations supporting generic accessibility can further drive volume growth. In addition, emphasis on erectile dysfunction management during primary check-ups presents an opportunity to educate patients and eliminate hesitation. However, maintaining brand loyalty with flagship products amid intense price wars poses a challenge. Overall, advancements in medical technology along with growing focus on sexual wellness are likely to augment sales in global sildenafil market.
Viagra Professional
Increasing prevalence of erectile dysfunction: The prevalence of erectile dysfunction (ED) has been steadily rising across the globe. According to data provided by Cleveland Clinic Foundation, a non-profit academic medical center, around 30-41% of men suffer from ED by the age of 40. The increasing geriatric population and age-related health issues are contributing to the growing patient pool. The high unmet needs of ED patients are expected to drive the demand for sildenafil drugs in the near future. With improving awareness and acceptance for ED treatment, the adoption of sildenafil is likely to increase among patients. In addition, emphasis on erectile dysfunction management during primary check-ups presents an opportunity to educate patients and eliminate hesitation.
- Legal regulations in Ireland restrict sildenafil sales without prescription.
- Low-cost sildenafil options are often found in online Irish pharmacies.
- Fake sildenafil is common online; verify seller credentials before purchase.
- Some clinics in Ireland offer subsidized sildenafil for specific conditions.
- Cost of sildenafil may include consultation or delivery fees in Ireland.
However, maintaining brand loyalty with flagship products amid intense price wars poses a challenge. Overall, advancements in medical technology along with growing focus on sexual wellness are likely to augment sales in global sildenafil market. Increasing prevalence of erectile dysfunction: The prevalence of erectile dysfunction (ED) has been steadily rising across the globe. According to data provided by Cleveland Clinic Foundation, a non-profit academic medical center, around 30-41% of men suffer from ED by the age of 40. The increasing geriatric population and age-related health issues are contributing to the growing patient pool. The high unmet needs of ED patients are expected to drive the demand for sildenafil drugs in the near future. With improving awareness and acceptance for ED treatment, the adoption of sildenafil is likely to increase among patients. Expiry of patents leading to launch of generics: The patent expiry of branded sildenafil drugs such as Viagra has led to the launch of generic versions by many pharmaceutical companies. The low cost of generics compared to branded equivalents is boosting their adoption. Companies are focused on developing generic sildenafil formulations to capture the market share. The availability of generics has made ED treatment more accessible and affordable, thereby driving the growth of the sildenafil drug market.
- The average price of sildenafil in Ireland for a 30-tablet pack is circa €35-€45.
- Some Irish pharmacies bundle sildenafil with other ED treatments for deals.
- Certain online platforms offer subscription services for regular sildenafil supply.
- Prices may be higher in rural areas compared to urban centers.
- Always verify if the sildenafil complies with Irish medical standards before buying.
Favorable reimbursement policies and government support: The reimbursement coverage for ED drugs by public and private healthcare insurance providers is improving in many countries. This is encouraging patients to opt for sildenafil treatment. Initiatives by governments and NGOs to spread awareness about ED and available treatment options led to the greater adoption of sildenafil drugs. Government support to expand healthcare infrastructure is also fueling the growth of the sildenafil drug market. Emerging use in other therapeutic applications: While ED remains the primary application sildenafil has shown promise in other indications like pulmonary hypertension and altitude sickness. The widening scope of sildenafil in other untapped applications and ongoing research for further therapeutic uses represents significant growth opportunities for the market in the long run. Expanding clinical evidence and physician prescriptions will support the increasing utilization of sildenafil drugs. Development of novel drug delivery systems: Pharmaceutical companies are engaged in developing innovative drug delivery systems such as oral disintegrating tablets, nasal sprays, topical gels, and others to improve efficacy, safety, convenience, and compliance of sildenafil treatment. The advent of advanced drug delivery platforms provides an opportunity to differentiate brand offerings and gain competitive advantage in the market.
| Source | Average Price per Tablet (€) | Delivery Fee (€) | Notes |
|---|---|---|---|
| Local Pharmacy | 14 | 0 | In-store pickup |
| Online Pharmacy | 9 | 2 | Discreet shipping |
| Internet Sellers | 7-10 | 5-10 | Varies |